SAN DIEGO, Sept. 27 /PRNewswire/ — Clinicians from three U.S.
hospitals today reported significant progress in the fight against
deadly IV catheter-related bloodstream infections (CRBSI). Data
analyzed and presented by clinicians from St. Joseph’s Mercy
Hospital in Hot Springs, Ark.; Bethesda North Hospital in
Cincinnati; and the VA Medical Center in Seattle showed that the
hospitals virtually eliminated such infections, which annually kill
some 62,500 hospital patients nationwide.
(Logo: http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20100706/CAREFUSIONLOGO)
The new findings are noteworthy because few U.S. hospitals have
been able to achieve greater than an 80 percent reduction in CRBSI
rates. Clinical research, presented Sept. 25 at the annual meeting
of the Association for Vascular Access, document the effectiveness
of the CareFusion MaxPlus Clear positive displacement needleless
access connector in combination with clinical practices. The
results further support use of MaxPlus®
technology to assist in central line-associated bloodstream
infections (CLABSI) reduction efforts; eight additional research
reports, either published or presented, show virtually the same
results.
CareFusion’s MaxPlusClear technology provides a
visual cue to perform best practices more thoroughly including
priming, disinfection and flushing and therefore helps promote the
performance of best practices. In addition, the smooth top provides
an optimal surface for easy disinfection.
Annually, CRBSIs affect 250,000 U.S. hospital patients; about 25
percent of such cases result in death. In addition to the human
toll, the financial costs to the health care system are staggering.
These preventable infections typ
‘/>”/>
